Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
PT-141 (Bremelanotide) is a synthetic peptide analog derived from melanocortin-based compounds and is commonly studied for its interaction with melanocortin receptors. In controlled laboratory settings, PT-141 has been evaluated for receptor-binding activity and downstream signaling pathways associated with the central melanocortin system. Preclinical research has examined its influence on neurological and regulatory signaling mechanisms under experimental conditions. This product is supplied strictly for laboratory research use only. It is not approved for human consumption, diagnostic use, or therapeutic application.
PT-141 (Bremelanotide) is a synthetic peptide analog derived from melanocortin-based compounds and is commonly studied for its interaction with melanocortin receptors. In controlled laboratory settings, PT-141 has been evaluated for receptor-binding activity and downstream signaling pathways associated with the central melanocortin system. Preclinical research has examined its influence on neurological and regulatory signaling mechanisms under experimental conditions. This product is supplied strictly for laboratory research use only. It is not approved for human consumption, diagnostic use, or therapeutic application.